Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Negative illness perceptions increase emotional distress, worsening OCD symptoms in alopecia areata patients.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Trichoscopy helps diagnose and track alopecia areata by examining specific hair and scalp markers.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.